Zusammenfassung
Zielsetzung
Die Effektivität eines Holmiumlasersystems mit mittlerer Leistung (50 W) und neuartigem Gewebemorcellator für die transurethrale Laserenukleation der Prostata (TULP) wird analysiert und Literaturergebnissen bisheriger Holmiumlaser-Enukleationen der Prostata (HoLEP; 100 W) gegenübergestellt.
Material und Methoden
Von Dezember 2003 bis Januar 2008 wurden 129 Patienten mit benigner Prostatahyperplasie mittels TULP behandelt. Bei 45 Fällen mit 25-W-Laserleistung (Gruppe A; 2,0 J, 12 Hz) erfolgte die Gewebefragmentierung mit bipolarem Resektoskop (VISTA/ACMI), bei 39 Patienten (Gruppe B; 2,0 J, 12 Hz) wurde ein neuartiger Morcellator (Wolf) verwendet. 45 Patienten wurden mit 40 W (Gruppe C; 2,2 J, 18 Hz) therapiert und mittels Matched-pair-Analyse 45 TURP-Patienten (Gruppe D) gegenübergestellt. Außerdem erfolgte eine Literaturrecherche zur HoLEP.
Ergebnisse
Die bipolare Gewebefragmentierung verlängerte die Operationszeit (135 vs. 131 vs. 96 min) signifikant. Die Morcellationsgeschwindigkeit lag im Mittel bei 2,8 (1,3–5,2) g/min ohne Komplikationen. Die Resektionsgeschwindigkeit der 40-W-TULP war vergleichbar mit der TURP (0,71 vs. 0,76 g/min). Die Transfusionsrate war niedriger als bei TURP (8 vs. 12%) mit entsprechend geringerer Hb-Differenz (3,1 vs. 3,8 mg/dl). Die Katheterzeiten (3,4 vs. 4,1 Tage) waren vergleichbar bei signifikant kürzerem stationärer Aufenthalt nach TULP (5,2 vs. 6,8 Tage). Die Komplikationsrate war signifikant geringer (6,6 vs. 13,3%). Entscheidend für die Effizienz von HoLEP war die Einführung des Morcellators: Die Resektionszeiten stiegen von 0,34–0,61 g/min auf 0,48–0,82 g/min Günstiger als 40-W-TULP erweist sich HoLEP hinsichtlich Transfusionsrate (0–4 vs. 8%) und Katheterzeit (1,1–1,5 vs. 3,4 Tage). Die Komplikationsraten und funktionelle Ergebnisse sind gleichwertig.
Schlussfolgerungen
Die transurethrale Laserenukleation der Prostata lässt sich auch mit einem kostengünstigeren System von maximal 50 W durchführen. Das Verfahren ist technisch anspruchsvoll und erfordert endoskopische Erfahrung. Die Resektionsgeschwindigkeiten sind vergleichbar bei geringerem Blutungsrisiko der HoLEP. Technische Neuerungen (z. B. Thulliumlaser) werden die Handhabung der Laserenukleation verbessern.
Abstract
Purpose
To evaluate the efficacy and safety of an intermediate power (50 W) holmium:YAG laser system for transurethral enucleation of the prostate (TULP) with the use of a new mechanical morcellator. Our results are compared with the results of high-powered holmium laser enucleation (HoLEP) presented in the literature.
Material and Methods
From December 2003 to January 2008, 129 patients with benign prostatic hyperplasia were treated by TULP. In 45 cases (group A; 2.0, 12 Hz) we used a bipolar resectoscope (VISTA/ACMI) for morcellation, whereas after that morcellation was accomplished with a modified endoscopic shaver (Wolf). Thirty-nine patients were treated using 25 W (group B; 2.0 J, 12 Hz), and 45 patients were treated using 40 W (group C; 2.2 J 18 Hz), who were compared with 45 matched-pair patients who received transurethral resection of the prostate (TURP; group D). Finally, the literature on HoLEP was reviewed.
Results
Bipolar morcellation significantly prolonged the operating time (135 vs. 131 vs. 96 min). The morcellation speed averaged 2.8 (range 1.3–5.2) g/min with no complications. The resection speed (retrieval rate) of 40-W TULP was comparable to that for TURP (0.71 vs. 0.76 g/min). The transfusion rate was lower than for TURP (8% vs. 12%), with a smaller Hb difference (3.1 vs. 3.8 mg/dl). Catheter times (3.4 vs. 4.1 days) were similar; however, hospital stay was significantly shorter after TULP (5.2 vs. 6.8 days). The complication rate was significantly lower (6.6% vs. 13.3%). The efficacy of HoLEP significantly improved with introduction of the morcellator: Resection speed increased from 0.34–0.61 g/min to 0.48–0.82 g/min. HoLEP was better than 40-W TULP regarding transfusion rate (0–4% vs. 8%) and catheter time (1.1–1.5 vs. 3.4 days). Complications and functional results were similar.
Conclusion[Überschrift]
The intermediate-power 50-W holmium laser together with the new morcellator enable safe transurethral enucleation of the prostate. As with HoLEP, the procedure has a significant learning curve. The retrieval times of TULP are similar to those for HoLEP, but the risk of bleeding is higher. New modifications (i.e., thullium laser) will further improve the technique of laser enucleation.
Literatur
Ahyai SA, Lehrich K, Kuntz RM (2007) Holmium laser enucleation versus transurethral resection of the prostate: 3 year follow-up results of a randomized clinical trial. Eur Urol 52: 1456–1464
Bach T, Hermann TR, Ganzer R et al. (2007) Revolix vaporesection of the prostate: Initial results after 54 patients with an one-year follow-up. World J Urol 25: 257–262
Bachman A, Schürch L, Ruszat R et al. (2005) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48: 965–972
Barba M, Fastenmeier K, Hartung R (2003) Electrocautery: Principles and practice. J Endourol 17: 541–555
Berger AP, Wirtenberger W, Bektic J et al. (2004) Safer transurethral resection of the prostate: coagulating intermittent cutting reduces hemostatic complications. J Urol 171: 289–291
Bliem F, Lamche M, Janda R, Schramek P (2003) Blood loss and absorption in TURP vs TUVRP under low pressure and high pressure conditions. Urologe A 42: 1477–1488
Elzayat EA, Elhilali MM (2006) Holmium laser enucleation of the Prostate (HoLEP): The endourological alternative to open prostatectomy. Eur Urol 49: 87–91
Elzayat EA, Elhilali MM (2007) Holmium laser enucleation of the prostate (HoLEP): Long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol 52: 1465–1472
Faul P (1993) Video-TUR: raising the gold standard. Eur Urol 24: 256–261
Gilling PJ, Mackey M, Cresswell M et al. (1999) Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup. J Urol 162: 1640–1644
Gilling PJ, Kennett KM, Fraundorfer M (2000) Holmium laser resection of the prostate: results of a randomized trial with 2 years of follow-up. J Endourol 14: 757–760
Gilling P (2008) Holmium laser enucleation of the prostate. BJU Int 101: 131–142
Gratzke C, Schlenker B, Seitz M et al. (2007) Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol 177: 1419–1422
Gupta N, Kumar SR, Dogra PN, Seth A (2006) Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int 97: 85–89
Hartung R, Leyh H, Liapi C et al. (2001) Coagulating intermittent cutting. Improved high-frequency surgery in transurethral prostatectomy. Eur Urol 39: 676–681
Hahn RG, Ekengren JC (1993) Patterns of irrigating fluid absorption during transurethral resection of the prostate as indicated by ethanol. J Urol 149: 502–506
Haupt G, Pannek J, Benkert S et al. (1997) Transurethral resection of the prostate with microprocessor controlled electrosurgical unit. J Urol 158: 497
Heidler H (1999) Frequency and causes of fluid absorption: a comparison of three techniques for resection of the prostate under continuous pressure monitoring. BJU Int 83: 619–622
Hochreiter WW, Thalmann GN, Burkhard FC, Studer UE (2002) Holmium laser enucleation of the prostate combined with electrocautery resection: The mushroom technique. J Urol 168: 1470–1474
Horninger W, Unterlechner H, Strasser H, Bartsch G (1996) Transurethral prostatectomy: mortality and morbitidy. Prostate 28: 195–198
Kuntz RM, Ahyai S, Lehrich K, Fayad A (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: A randomized prospective trial in 200 patients. J Urol 172: 1012–1016
Kuntz RM (2007) Laser treatment of benign prostatic hyperplasia. World J Urol 25: 241–247
Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostate greater than 100 grams: 5-year follow-up results of a randomized clinical trial. Eur Urol 53: 160–168
Le Duc A, Gilling PJ (1999) Holmium laser resection of the prostate. Eur Urol 35: 155–160
Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified. BJU Int 83: 227–237
Madersbacher S, Alivizatos G, Nordling J et al. (2004) EAU 2004 Guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46: 547–554
Madersbacher S, Lackner J, Brössner C et al. (2005) Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47: 499–504
Matlaga BR, Miller NL, Lingeman JE (2007) Holmium laser treatment of benign prostatic hyperplasia: an update. Curr Opin Urol 17: 27–31
Michel MS, Köhrmann KU, Weber A et al. (1996) Rotoresect: New technique for resection of the prostate. Experimental phase. J Endourol 10: 473–478
Montorsi F, Naspro R, Salonia A et al. (2004) Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 172: 1926–1929
Moody JA, Lingeman JE (2001) Holmium laser resection for prostate adenoma greater than 100 gm: comparison to open prostatectomy. J Urol 165: 459–462
Naspro R, Freschi M, Salonia A et al. (2004) Holmium laser enucleation versus transurethral resection of the prostate. Are histological findings comparable. J Urol 171: 1203–1206
Naspro R, Suardi N, Salonia A et al. (2006) Holmium laser enucleation of the prostate versus open prostatectomy >70 g: 24-month follow-up. Eur Urol 50: 563–568
Neill MG, Gilling PJ, Kennet KM et al. (2006) Randomized trial comparing holmium laser enucleation of prostate with plasmakiinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology 68: 1020–1024
Peterson MD, Matlaga BR, Kim SC et al. (2005) Holmium laser enucleation of the prostate for men with urinary retention. J Urol 174: 998–1001
Rassweiler J, Frede T, Seemann O, Schulze M (2003) Medium power Ho: YAG lasers. In: Gupta NP, Kumar R (eds) Holmium laser – Endourological applications. B.I. Publications, New Dehli, pp 58–61
Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP) – incidence, management, and prevention. Eur Urol 50: 969–980
Rassweiler J, Schulze M, Stock C et al. (2007) Bipolar transurethral resection of the prostate – technical modification and early clinical experience. Min Inv Therap 16: 11–21
Reich O, Seitz M, Gratzke C et al. (2006) Benignes Prostatasyndrom (BPS). Ablative Verfahren. Urologe A 45: 769–782
Seki N, Tatsugami K, Naito S (2007) Holmium laser enucleation of the prostate: Comparison of outcomes according to prostate size in 97 Japanese patients. J Endourol 21: 192–196
Seki N, Naito S (2008) Holmium laser for benign prostatic hyperplasia. Curr Opin Urol 18: 41–46
Shah HN, Mahajan AP, Sodha HS et al. (2007) Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol 177: 1468–1474
Shah HN, Mahajan AP, Sunil SS, Bansal MB (2007) Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of the literature. BJU Int 100: 94–101
Tan AHH, Gilling PJ, Kennet KM et al. (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign hyperplasia large glands (40 to 200 grams). J Urol 170: 1270–1274
Wilson LC, Gilling PJ, Williams A et al. (2006) A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 50: 569–573
Zwergel U (2001) Benignes Prostatahyperplasie-(BPH)-Syndrom. Operative und interventionelle Therapieoptionen. Urologe A 40: 319–329
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung hin: Übernahme der Reisekosten bei Operationsdemonstrationen durch die Firma StarMedTec, Starnberg.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rassweiler, J., Roder, M., Schulze, M. et al. Transurethrale Laserenukleation der Prostata mit dem Holmiumlaser. Urologe 47, 441–448 (2008). https://doi.org/10.1007/s00120-008-1684-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-008-1684-7
Schlüsselworte
- Benigne Prostatahyperplasie
- Laserenukleation
- Holmiumlaser
- Morcellment
- Prostatektomie
- Transurethrale Prostataresektion